UC partnering in webinar on treatments for young people at risk for substance use disorders
Event Information (passed)
A free webinar, "Tailoring Conversations and Treatment to Adolescents and Young Adults at Risk for Substance Use Disorder" is being offered Thursday, Aug. 8, 2019, from 1 p.m. to 2 p.m. Designed for health care professionals working with youth and young adults in the fields of nursing, pharmacy, medicine, social work, counseling and teaching, the webinar is co-sponsored by the University of Cincinnati College of Allied Health Sciences and College of Education, Criminal Justice and Human Services.
This session is part of the SBIRT webinar series. SBIRT, which stands for screening, brief intervention and referral to treatment, is a comprehensive, integrated public health approach to the delivery of early intervention and treatment services for persons with substance abuse disorders, as well as those who are at risk of developing those disorders. The webinar series is part of the Adolescent SBIRT project which is a collaboration with the National Opinion Research Center at the University of Chicago. Funding is provided by the Conrad N. Hilton Foundation.
Click here for more information about the webinar and here to register.
Additional Contacts
Related Stories
Driven by curiosity, guided by care
May 14, 2026
Max Wilson, a University of Cincinnati College of Allied Health Sciences health sciences major on the pre-physician assistant track, found his path expanding beyond the classroom and into hands-on research focused on human performance and patient care.
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.